ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

Trial Tests Virtual Colonoscopy Vs. Standard; Polyp Study Favors Colonoscopy Over Barium

August 25, 2000

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

February 26, 2010

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976